New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
09:16 EDTALSK, GTAT, NVTL, FEYE, VMEM, NLNK, SWY, SKUL, BIG, FL, FRM, DLIAOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Foot Locker (FL), up 5.5%... Skullcandy (SKUL), up 25%... Big Lots (BIG), up 16%... Alaska Communications (ALSK), up 11%...ALSO HIGHER: dELiA's (DLIA), up 11% after Tiger Global Management reports 6.3% passive stake in the company... GT Advanced (GTAT), up 7% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Furmanite (FRM), down 3.8%... Novatel Wireless (NVTL), down 23%... Peregrine Pharmaceuticals (PPHM), down 10%. ALSO LOWER: NewLink (NLNK), down 9.7% after saying will continue IMPRESS Phase 3 study of algenpantucel-L... Violin Memory (VMEM), down 12.4% after earnings, downgrade at BofA/Merrill... FireEye (FEYE), down 6.6% after 14M share secondary offering of stock priced at $82.00... Safeway (SWY), down 3% after announcing a deal to be acquired by Albertsons for about an estimated $40 per share in a merger that had been reported on extensively.
News For FL;SKUL;DLIA;BIG;SWY;FRM;GTAT;NLNK;FEYE;ALSK;VMEM;NVTL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 24, 2014
07:33 EDTNLNKMerck, NewLink enter licensing, collaboration agreement for Ebola vaccine
Merck (MRK) and NewLink Genetics (NLNK) announced that they have entered into an exclusive worldwide license agreement to research, develop, manufacture, and distribute NewLink's investigational rVSV-EBOV vaccine candidate. Under the terms of the agreement, Merck will be granted the exclusive rights to the rVSV-EBOV vaccine candidate as well as any follow-on products. The vaccine candidate is under an exclusive licensing arrangement with a wholly-owned subsidiary of NewLink Genetics. Under these license arrangements, the PHAC retains non-commercial rights pertaining to the vaccine candidate. Phase I clinical trials of the rVSV-EBOV vaccine are now underway at the Walter Reed Army Institute of Research and the NIAID at the NIH. Additional Phase I studies are underway or planned to begin in the near future at clinical research centers in Switzerland, Germany, Kenya, and Gabon in a World Health Organization-coordinated effort, and in Canada by the Canadian Immunization Research Network.
07:31 EDTNLNKMerck, NewLink Genetics enter into agreement for investigational Ebola vaccine
Subscribe for More Information
November 21, 2014
15:57 EDTFLFoot Locker weakness a buying opportunity, says Jefferies
Subscribe for More Information
15:05 EDTFLFoot Locker reverses to session lows in last hour of trading
Subscribe for More Information
10:03 EDTFLFoot Locker says constantly looking at M&A opportunities
09:20 EDTFLFoot Locker sees Q4 SSS gain in the mid-single digits
Subscribe for More Information
09:17 EDTFLOn The Fly: Pre-market Movers
Subscribe for More Information
07:01 EDTFLFoot Locker reports Q3 EPS 83c, consensus 79c
Subscribe for More Information
November 20, 2014
15:28 EDTFLNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Foot Locker (FL), consensus 79c; ANN Inc. (ANN), consensus 68c; Hibbett Sports (HIBB), consensus 62c; Berry Plastics (BERY), consensus 37c; Sirona Dental Systems (SIRO), consensus 90c.
15:14 EDTNLNKTraveler returned from Mali being tested for Ebola in NYC, Daily News reports
Subscribe for More Information
10:55 EDTFEYEFireEye December calls active
Subscribe for More Information
07:25 EDTFLFoot Locker volatility increases into Q3 and outlook
Subscribe for More Information
November 19, 2014
09:01 EDTFEYEBig data for security could reach $4B-$5B, says FBR Capital
Subscribe for More Information
07:51 EDTFEYEClearing House Payments Company to hold a conference
Subscribe for More Information
07:40 EDTFEYEUBS to hold a conference
Global Technology Conference to be held in Sausalito, California on November 18-20 with webcasted company presentations to begin on November 19 at 10:45 am; not all company presentations may be webcasted.Webcast Link
November 17, 2014
15:22 EDTFLFoot Locker volatility increases into Q3 and outlook
Subscribe for More Information
08:44 EDTNLNKNebraska Medical announces death of third Ebola patient
The Nebraska Medical Center said via Twitter, "We are sorry to announce that the 3rd Ebola patient, Dr. Martin Salia, has passed away as a result of the advanced symptoms of the disease." Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED).
06:48 EDTFEYEState Department hacked, NY Times reports
Subscribe for More Information
November 16, 2014
19:34 EDTFEYEFinancial services firms plan $2B increase in cybersecurity spending, WSJ says
Subscribe for More Information
November 14, 2014
07:46 EDTFEYEFireEye growth outlook has improved, says Wells Fargo
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use